Progenics Pharma (PGNX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	98.89M
Accounts receivable	3.94M
Other current assets
Total current assets	106.61M
Auction rate securities
Fixed assets, at cost, net of accumulated depreciation and amortization	3.9M
Other assets
Total assets	156.94M
Accounts payable and accrued expenses
Deferred revenue - current
Other current liabilities	26K
Total current liabilities	13.82M
Deferred revenue - long term
Other liabilities
Total liabilities	45.91M
Commitments and contingencies (Note 7)
Common stock	91K
Additional paid-in capital	596.98M
Accumulated deficit	-483.37M
Accumulated other comprehensive loss	-74K
Treasury stock	-2.74M
Total stockholders' equity	110.89M
Total liabilities and stockholders' equity	156.94M

Entities mentioned with PGNX

View All Entities